Page last updated: 2024-10-31

neostigmine and Central Nervous System Diseases

neostigmine has been researched along with Central Nervous System Diseases in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RadzimiƄski, A1
Latkowski, B1
Duvoisin, RC1
Katz, R1

Reviews

1 review available for neostigmine and Central Nervous System Diseases

ArticleYear
[Usefulness of electronystagmography in neurologic diagnosis].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1971, Apr-05, Volume: 26, Issue:14

    Topics: Brain Concussion; Central Nervous System Diseases; Electrooculography; Eye Movements; Fixation, Ocul

1971

Other Studies

1 other study available for neostigmine and Central Nervous System Diseases

ArticleYear
Reversal of central anticholinergic syndrome in man by physostigmine.
    JAMA, 1968, Nov-25, Volume: 206, Issue:9

    Topics: Aged; Ataxia; Central Nervous System Diseases; Child; Cognition Disorders; Delirium; Female; Halluci

1968